Table 5.

Effect of PLL on Haematological Parameters in Sarcoma-180 Solid Tumor Bearing Mice

	Sarcoma-180 Control (2 x 106 cells/mouse)	Poly L-lysine 20 mg/kg b.w	Poly L-lysine 40 mg/kg b.w	Std. drug 20 mg/kg. b.w	Normal mice
Hemoglobin (gm %)	10.2± 0.01*	7.3± 0.05*	8.9± 0.08*	8.6± 0.08*	13.9± 0.12*
Erythrocytic (RBC) (million/mm3)	3.79± 0.04*	4.48± 0.04*	5.8± 0.03*	5.7± 0.03*	6.90± 0.02*
Leucocytic (WBC) (103 cells/mm3)	16.86± 0.02*	11.18± 0.05*	5.11± 0.05*	4.25± 0.05*	4.85± 0.09 *
Neutrophil	68.4± 0.05*	42.35± 0.03*	26.4± 0.02*	30.1± 0.02*	17.5± 0.03*
Lymphocyte (%)	35.1± 0.11*	45.0± 0.04*	63.0± 0.09*	65.0± 0.09*	68.2± 0.25*
Monocyte (%)	1.6± 0.04*	1.7± 0.03*	1.7± 0.03*	1.8± 0.03*	2.3± 0.02*

Each point represent the mean ±SEM; (n, 6 mice per group); *p<0.05 statistically significant when compared with EAC control group.